Research Associate III, In vitro antibody discovery (s411)

  • Contract Duration: 12+ months
  • Research & Development
  • Cambridge, MA

Website Lenox Executive Search

Lenox Executive Search is seeking a Research Associate III, to fill a 12+ month contractual role with a leading global pharmaceutical company located in Cambridge, MA. Our client is committed to be a world-class biologics research organization bringing next generation, transformative therapies to their patients. Their global Large Molecule Research (LRM) platform consists of five sites, and approximately 550 personnel focused on antibodies, nanobodies and synthorins as therapeutic modalities. The platform enables and partners closely with other research platforms and therapeutic areas (Immunology, Oncology, Rare Disease and Neurology) in the discovery and ultimate delivery of new candidate molecules into our pipeline.

To continue to build on our success in these efforts we are seeking an experienced, versatile, and self-driven individual to join the Antibody Discovery group. This position will directly contribute to lead discovery efforts of next generation biotherapeutics across all therapeutic areas, with strong focus on multi-specific modalities. The successful candidate will have demonstrated in-depth understanding of in vitro display methodologies (i.e., mammalian, phage or yeast), antibody discovery workflows, protein engineering, sequence analysis and excel in a fast-paced environment. The candidate will be responsible for advanced lab activities, including platform technology and innovation, and is expected to impact at the organizational level in a matrix team environment.
This is an exciting opportunity to join a group of accomplished scientists focused on the design and realization of advanced therapeutic modalities.

• Execute discovery campaigns using phage- and yeast-displayed antibody libraries.
• Execute hands-on lab work to apply molecular biology, high throughput screening and rational antibody engineering techniques to generate therapeutic lead molecules.
• Develop HT-amenable biochemical assays (ELISA, flow cytometry) in support of hit identification.
• Manage several projects simultaneously and act as point of accountability for in vitro display efforts on projects.
• Work collaboratively with other antibody discovery teams, locally and globally.
• Analyze and present data, both in written reports and oral presentations.
• Effectively manage projects and resources to maximize progress.

• Master’s degree in Biochemistry, Molecular or Structural Biology or a closely related field with focus on antibody engineering plus minimum 1-year relevant research experience in an academic or biopharmaceutical setting or Bachelor’s degree with 4 years minimum relevant research experience.
• Experience with phage display, molecular biology, mammalian cell culture and high-throughput binding screening is required.
• Experience with biochemical assay development and multi-specific modalities is highly preferred.
• Highly analytical mind, attention to detail, and organizational skills are critical.
• Self-starter with a strong sense of responsibility, integrity, and a collaborative spirit.
• Ability to work independently to design and trouble-shoot experiments.

Upload your resume here.

Our COVID-19 Policy

As with other larger employers and customer-facing organizations, Lenox Executive Search is carefully monitoring the situation regarding Coronavirus (COVID-19), with a particular focus on public health guidance offered by the CDC and state officials.  We are reaching out to make you aware of our activities and preparations in light of the spread of the Coronavirus (COVID-19). Our number one priority is the safety of our employees, clients and the broader community. Given the current unpredictable nature of the spread of COVID-19, and in an abundance of caution, Lenox Executive Search has implemented the following practices immediately:
  • We have increased our overnight cleaning activities to ensure frequently touched areas are being disinfected and sanitized.
  • We have implemented social distancing techniques to minimize the typical face-to-face- contact by utilizing teleconference calls and flexible workspaces.  We have suspended non-essential business travel for our employees and have asked that inter-company meetings be conducted via teleconference. In addition, we kindly ask all of our customers to help us maintain a handshake-free zone at all Lenox Executive Search locations.
  • We have asked employers who feel ill to stay home.
  • We have convened a team of senior leaders who meet daily to discuss the situation and stand ready to take additional steps, if necessary.
  • We have measures in place to ensure our operations can effectively continue so that we can provide our clients uninterrupted service.  Lenox Executive Search already had robust and detailed business continuity plans in place.
– The Lenox Executive Search Team